Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2020 06:30 ET | Source: CENTOGENE GmbH

CENTOGENE Announces the Scientific Publication of a holistic solution in the preventive testing of COVID-19

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that...
July 06, 2020 06:30 ET | Source: CENTOGENE GmbH

CENTOGENE Announces Partnership with OESIS Network for COVID-19 PCR Testing for US School Populations

CAMBRIDGE, Mass. and SANTA MONICA, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, and the OESIS Network Inc, an...
July 02, 2020 08:03 ET | Source: CENTOGENE GmbH

CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 02, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
May 08, 2020 14:00 ET | Source: Centogene AG

Blueprint for Germany: CENTOGENE Provides Coronavirus Testing for German High School

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 08, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
May 05, 2020 09:30 ET | Source: Centogene AG

CENTOGENE Announces Global Expansion of COVID-19 Testing

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN,, May 05, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...